LA
ZBH icon

Lee Ainslie’s Zimmer Biomet ZBH Stock Holding History

Lee Ainslie’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-729
Closed -$90K – 392
2021
Q4 		$90K Sell
729
-20,082
-96% -$2.63M ﹤0.01% 231
2021
Q3 		$2.96M Buy
20,811
+11,582
+125% +$1.7M 0.03% 143
2021
Q2 		$1.44M Sell
9,229
-9,990
-52% -$1.62M 0.01% 206
2021
Q1 		$2.99M Buy
19,219
+12,844
+201% +$1.99M 0.03% 112
2020
Q4 		$954K Buy
6,375
+945
+17% +$133K 0.02% 237
2020
Q3 		$718K Buy
5,430
+2,231
+70% +$291K 0.01% 365
2020
Q2 		$371K Buy
+3,199
New +$369K 0.01% 478
2019
Q3 		– Sell
-38,337
Closed -$4.38M – 407
2019
Q2 		$4.38M Buy
+38,337
New +$4.49M 0.06% 181

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lee Ainslie's ZBH Position: Q1 2022 in Review

Lee Ainslie sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 729 shares — an estimated $90K sold.

Lee Ainslie first reported a position in ZBH in Q2 2019 and held it in 8 quarters. The position peaked at $4.38M in Q2 2019. 978 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

  • Lee Ainslie reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
  • Lee Ainslie sold 729 Zimmer Biomet shares in Q1 2022, an estimated $90K.
  • Lee Ainslie first reported a position in Zimmer Biomet in Q2 2019 and held it in 8 quarters.
  • Lee Ainslie's Zimmer Biomet position peaked at $4.38M in Q2 2019.
  • 978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Maverick Capital's 13F filing for Q1 2022, filed 16 May 2022.